Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 23 Jan 2023 for Aura Biosciences, Inc.. Read the official filing
Filing timeline
BuySaleMark De Rosch
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Mark De Rosch: trading record in brief
Mark De Rosch (senior executive) discloses dealings in Aura Biosciences, Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 28 October 2021 and the latest from 19 January 2023.
The open-market record consists of 1 sale worth €14k, with no purchase. Other entries cover 2 share grants.
On 23 January 2023 came the latest disclosure, a share grant in Aura Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark De Rosch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
42,250 shares0Common StockSEC:0000899243-23-002436:0
1,115 shares@ US$12.4574100.0% of flowCommon StockSEC:0000899243-22-034834:0
17,500 shares0Common StockSEC:0000899243-21-042089:0
3 of 3 declarations
